Ascendis Pharma A/S ASND
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$4.97M (12 inflow days, 8 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 50.6% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 5.62% to 4.56% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Wellington Management Group | Mutual Fund | 2026/Q4 | +1,521,763 | 4.7% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q4 | +1,234,734 | 13.9% |
| Vestal Point Capital, LP | Hedge Fund | 2026/Q4 | +365,000 | 1.1% |
| Chevy Chase Trust Company | Mutual Fund | 2026/Q4 | +361,364 | 0.6% |
| Westfield Capital Management Company, L.P. | Mutual Fund | 2026/Q4 | +326,760 | 7.8% |
| Principal Global Investors, LLC | Mutual Fund | 2026/Q4 | +292,728 | 1.8% |
| Macquarie Investment Management Business Trust | Mutual Fund | 2026/Q4 | +265,839 | 0.9% |
| Artal Group S.A. | VC/PE Fund | 2026/Q4 | +130,000 | 0.2% |
| OrbiMed Advisors LLC | VC/PE Fund | 2026/Q4 | +100,744 | 0.5% |
| BNY Mellon Asset Management | Mutual Fund | 2026/Q4 | +97,759 | 0.6% |
| Arrowstreet Capital, Limited Partnership | Mutual Fund | 2026/Q4 | +95,335 | 0.3% |
| Bank of America Corporation | Public Company | 2026/Q4 | +83,068 | 0.4% |
| State Street Global Advisors | Mutual Fund | 2026/Q4 | +76,251 | 0.9% |
| California Public Employees' Retirement System | Government Pension Fund | 2026/Q4 | +74,449 | 0.1% |
| D. E. Shaw & Co., L.P. | Hedge Fund | 2026/Q4 | +74,317 | 0.2% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 7 Sep 2026 | Mads Bodenhoff | Senior VP, Head of Finance & Principal Accounting Officer | Derivative Exercise and Sale | -3,000 | $270.19 | – |
| 1 Sep 2026 | Lars Holtug | Independent Director | Open Market Disposition | -236 | $264.13 | 4,000 |
| 13 Aug 2026 | Jean-Jacques Bienaime | Non-Executive Director | Open Market Acquisition | +2,000 | $246.91 | 2,900 |
| 1 Jun 2026 | Scott Smith | CFO, Executive VP & Member of Executive Board | Open Market Acquisition | +100 | $219.00 | 4,367 |
| 28 May 2026 | Jean-Jacques Bienaime | Non-Executive Director | Open Market Acquisition | +500 | $223.76 | 900 |
| 28 May 2026 | Scott Smith | CFO, Executive VP & Member of Executive Board | Open Market Acquisition | +250 | $223.32 | 4,267 |
| 25 May 2026 | Jean-Jacques Bienaime | Non-Executive Director | Open Market Acquisition | +400 | $239.37 | 400 |
| 10 May 2026 | Flemming Jensen | Executive Vice President of Product Supply & Quality | Open Market Disposition | -19,460 | $238.49 | – |
| 13 Apr 2026 | Jean-Jacques Bienaime | Non-Executive Director | Derivative Sale to Issuer | -9,160 | – | – |
| 13 Apr 2026 | Jean-Jacques Bienaime | Non-Executive Director | Other Derivative Acquisition | +9,160 | $249.84 | 9,160 |
| 22 Mar 2026 | Jean-Jacques Bienaime | Non-Executive Director | Initial Statement of Beneficial | +0 | – | 9,160 |
| 17 Mar 2026 | Albert Cha | Independent Chairperson | Initial Statement of Beneficial | +0 | – | 3,730 |
| 17 Mar 2026 | Jan Mikkelsen | President, CEO, Member of Executive Board & Executive Director | Initial Statement of Beneficial | +0 | – | 68,604 |
| 17 Mar 2026 | Michael Jensen | Executive VP, Chief Legal Officer & Member of the Executive Board | Initial Statement of Beneficial | +0 | – | 94,259 |
| 17 Mar 2026 | Flemming Jensen | Executive Vice President of Product Supply & Quality | Initial Statement of Beneficial | +0 | – | 19,460 |
| 17 Mar 2026 | Pedersen Anni Lotte Sonderbjerg | Executive VP, Chief Administrative Officer & Member of the Executive Board | Initial Statement of Beneficial | +0 | – | 19,460 |
| 17 Mar 2026 | Mads Bodenhoff | Senior VP, Head of Finance & Principal Accounting Officer | Initial Statement of Beneficial | +0 | – | 36,804 |
| 17 Mar 2026 | William Fairey | Independent Director | Initial Statement of Beneficial | +0 | – | 2,117 |
| 17 Mar 2026 | Lisa Morrison | Independent Director | Initial Statement of Beneficial | +0 | – | 1,572 |
| 17 Mar 2026 | Scott Smith | CFO, Executive VP & Member of Executive Board | Initial Statement of Beneficial | +0 | – | 154,259 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 2,997,710 | 4.6% | 5.0 |
| 15 Oct 2026 | 3,132,475 | 4.8% | 4.2 |
| 30 Sep 2026 | 3,484,067 | 5.3% | 3.7 |
| 15 Sep 2026 | 3,961,960 | 6.0% | 4.9 |
| 31 Aug 2026 | 4,203,221 | 6.4% | 9.5 |
| 14 Aug 2026 | 3,687,311 | 5.6% | 6.3 |
No comments yet — be the first to weigh in on ASND.
Sign in to join the discussion.